BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1058 related articles for article (PubMed ID: 20134245)

  • 1. Production of biosurfactant lipopeptides Iturin A, fengycin and surfactin A from Bacillus subtilis CMB32 for control of Colletotrichum gloeosporioides.
    Kim PI; Ryu J; Kim YH; Chi YT
    J Microbiol Biotechnol; 2010 Jan; 20(1):138-45. PubMed ID: 20134245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coproduction of surfactin and iturin A, lipopeptides with surfactant and antifungal properties, by Bacillus subtilis.
    Sandrin C; Peypoux F; Michel G
    Biotechnol Appl Biochem; 1990 Aug; 12(4):370-5. PubMed ID: 2119191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and biochemical characterization of Iranian surfactin-producing Bacillus subtilis isolates and evaluation of their biocontrol potential against Aspergillus flavus and Colletotrichum gloeosporioides.
    Mohammadipour M; Mousivand M; Salehi Jouzani G; Abbasalizadeh S
    Can J Microbiol; 2009 Apr; 55(4):395-404. PubMed ID: 19396239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Purification and identification of surfactin isoforms produced by Bacillus subtilis B2 strain].
    Gao X; Yao S; Huong P; Joachim V; Wang J
    Wei Sheng Wu Xue Bao; 2003 Oct; 43(5):647-52. PubMed ID: 16281564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of surfactin produced by Bacillus subtilis isolate BS5.
    Abdel-Mawgoud AM; Aboulwafa MM; Hassouna NA
    Appl Biochem Biotechnol; 2008 Sep; 150(3):289-303. PubMed ID: 18437297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of surfactin and fengycin by Bacillus subtilis in a bubbleless membrane bioreactor.
    Coutte F; Lecouturier D; Yahia SA; Leclère V; Béchet M; Jacques P; Dhulster P
    Appl Microbiol Biotechnol; 2010 Jun; 87(2):499-507. PubMed ID: 20221757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postharvest Biological Control of Colletotrichum acutatum on Apple by Bacillus subtilis HM1 and the Structural Identification of Antagonists.
    Kim HM; Lee KJ; Chae JC
    J Microbiol Biotechnol; 2015 Nov; 25(11):1954-9. PubMed ID: 26428548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Purification and identification of iturin A from Bacillus subtilis JA by electrospray ionization mass spectrometry].
    Chen H; Yuan C; Cai K; Zheng Z; Yu Z
    Wei Sheng Wu Xue Bao; 2008 Jan; 48(1):116-20. PubMed ID: 18338587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of lipopeptides produced by Bacillus subtilis Czk1 isolated from the aerial roots of rubber trees.
    He CP; Fan LY; Wu WH; Liang YQ; Li R; Tang W; Zheng XL; Xiao YN; Liu ZX; Zheng FC
    Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Fusarium graminearum inhibitory lipopeptide from Bacillus subtilis IB.
    Wang J; Liu J; Chen H; Yao J
    Appl Microbiol Biotechnol; 2007 Sep; 76(4):889-94. PubMed ID: 17611753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of surfactin production by Bacillus subtilis isolate BS5.
    Abdel-Mawgoud AM; Aboulwafa MM; Hassouna NA
    Appl Biochem Biotechnol; 2008 Sep; 150(3):305-25. PubMed ID: 18682904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ESI LC-MS and MS/MS characterization of antifungal cyclic lipopeptides produced by Bacillus subtilis XF-1.
    Li XY; Mao ZC; Wang YH; Wu YX; He YQ; Long CL
    J Mol Microbiol Biotechnol; 2012; 22(2):83-93. PubMed ID: 22614917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fengycin C produced by Bacillus subtilis EA-CB0015.
    Villegas-Escobar V; Ceballos I; Mira JJ; Argel LE; Orduz Peralta S; Romero-Tabarez M
    J Nat Prod; 2013 Apr; 76(4):503-9. PubMed ID: 23461648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of lipopeptide isoforms by MALDI-TOF-MS/MS based on the simultaneous purification of iturin, fengycin, and surfactin by RP-HPLC.
    Yang H; Li X; Li X; Yu H; Shen Z
    Anal Bioanal Chem; 2015 Mar; 407(9):2529-42. PubMed ID: 25662934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and biochemical approaches for characterization of antifungal trait of a potent biocontrol agent Bacillus subtilis RP24.
    Grover M; Nain L; Singh SB; Saxena AK
    Curr Microbiol; 2010 Feb; 60(2):99-106. PubMed ID: 19777301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of bioactive lipopeptides, iturin A and surfactin from Bacillus subtilis.
    Thimon L; Peypoux F; Maget-Dana R; Roux B; Michel G
    Biotechnol Appl Biochem; 1992 Oct; 16(2):144-51. PubMed ID: 1457050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of a lipopeptide produced by Bacillus thuringiensis CMB26.
    Kim PI; Bai H; Bai D; Chae H; Chung S; Kim Y; Park R; Chi YT
    J Appl Microbiol; 2004; 97(5):942-9. PubMed ID: 15479409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of a Bacillus subtilis Strain Producing Multiple Types of Cyclic Lipopeptides and Evaluation of Their Surface-tension-lowering Activities.
    Habe H; Taira T; Imura T
    J Oleo Sci; 2017; 66(7):785-790. PubMed ID: 28674328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-candida effect of bacillomycin D-like lipopeptides from Bacillus subtilis B38.
    Tabbene O; Kalai L; Ben Slimene I; Karkouch I; Elkahoui S; Gharbi A; Cosette P; Mangoni ML; Jouenne T; Limam F
    FEMS Microbiol Lett; 2011 Mar; 316(2):108-14. PubMed ID: 21204933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of a mosquito pupicidal metabolite of a Bacillus subtilis subsp. subtilis strain.
    Geetha I; Manonmani AM; Paily KP
    Appl Microbiol Biotechnol; 2010 May; 86(6):1737-44. PubMed ID: 20130853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.